Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.48 |
| ▸ | CDK1 | P06493 | 1/20 | 0.47 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.46 |
| ▸ | TLR4 | O00206 | 1/20 | 0.41 |
| ▸ | LY96 | Q9Y6Y9 | 1/20 | 0.41 |
| ▸ | AKT1 | P31749 | 1/20 | 0.41 |
| ▸ | PRKCA | P17252 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33763 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL359292 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL16253 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL15435964 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL337163 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL39624 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL313538 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL128339 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL359493 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 | |
| SCHEMBL271582 | 1.00 | LDHA (0.48) | LDHACDK1CCNB1EPHX2TLR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3193834-A1 | PRE-SPRAY EMULSIONS AND POWDERS CONTAINING NON-POLAR COMPOUNDS | VIRUN, INC. (US) | 2017-07-26 | — | — | EP | claimed |
| US-20160193146-A1 | COMPOSITIONS CONTAINING NON-POLAR COMPOUNDS | VIRUN, INC. | 2016-07-07 | — | — | US | claimed |
| EP-2563164-B1 | NANOEMULSION INCLUDING SUCROSE FATTY ACID ESTER | VIRUN INC (US) | 2016-06-29 | — | — | EP | claimed |
| WO-2016044813-A9 | PRE-SPRAY EMULSIONS AND POWDERS CONTAINING NON-POLAR COMPOUNDS | VIRUN, INC. (US) | 2016-05-26 | — | — | WO | claimed |
| US-9320295-B2 | Compositions containing non-polar compounds | VIRUN, INC. (US) | 2016-04-26 | — | — | US | claimed |
| WO-2016044813-A1 | PRE-SPRAY EMULSIONS AND POWDERS CONTAINING NON-POLAR COMPOUNDS | VIRUN, INC. (US) | 2016-03-24 | — | — | WO | claimed |
| EP-2811847-A1 | BEVERAGE COMPOSITIONS CONTAINING NON-POLAR COMPOUNDS | VIRUN, INC. (US) | 2014-12-17 | — | — | EP | claimed |
| US-8741373-B2 | Compositions containing non-polar compounds | VIRUN, INC. (US) | 2014-06-03 | — | — | US | claimed |
| WO-2013120025-A1 | BEVERAGE COMPOSITIONS CONTAINING NON-POLAR COMPOUNDS | VIRUN, INC. (US) | 2013-08-15 | — | — | WO | claimed |
| EP-2563164-A1 | NANOEMULSION INCLUDING SUCROSE FATTY ACID ESTER | VIRUN, INC. (US) | 2013-03-06 | — | — | EP | claimed |
| US-20120016026-A1 | Compositions containing non-polar compounds | VIRUN, INC. | 2012-01-19 | — | — | US | claimed |
| WO-2011162802-A1 | COMPOSITIONS CONTAINING NON-POLAR COMPOUNDS | VIRUN, INC. (US) | 2011-12-29 | — | — | WO | claimed |
| WO-2011119228-A1 | NANOEMULSION INCLUDING SUCROSE FATTY ACID ESTER | VIRUN, INC. (US) | 2011-09-29 | — | — | WO | claimed |
| US-20110236364-A1 | Compositions containing non-polar compounds | VIRUN, INC. | 2011-09-29 | — | — | US | claimed |
| US-20220338502-A1 | EDIBLE SILK AND METHODS OF MAKING AND USING THEREOF | EVOLVED BY NATURE, INC. | 2022-10-27 | — | — | US | disclosed |
| EP-4017537-A1 | SILK PERSONAL CARE COMPOSITIONS | Evolved by Nature, Inc. (US) | 2022-06-29 | — | — | EP | disclosed |
| WO-2021055903-A1 | EDIBLE SILK AND METHODS OF MAKING AND USING THEREOF | EVOLVED BY NATURE, INC. (US) | 2021-03-25 | — | — | WO | disclosed |
| WO-2011162802-A1 | COMPOSITIONS CONTAINING NON-POLAR COMPOUNDS | VIRUN, INC. (US) | 2011-12-29 | — | — | WO | disclosed |
| WO-2011119228-A1 | NANOEMULSION INCLUDING SUCROSE FATTY ACID ESTER | VIRUN, INC. (US) | 2011-09-29 | — | — | WO | disclosed |
| US-20110236364-A1 | Compositions containing non-polar compounds | VIRUN, INC. | 2011-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110236364-A1 | Compositions containing non-polar compounds | ELOVL6, ELOVL3, ELOVL5 | LDHA 3297/4885CDK1 1792/4885CCNB1 1229/4885 |
| US-20160193146-A1 | COMPOSITIONS CONTAINING NON-POLAR COMPOUNDS | ELOVL6, ELOVL3, ELOVL5 | LDHA 3297/4885CDK1 1792/4885CCNB1 1229/4885 |
| US-20120016026-A1 | Compositions containing non-polar compounds | ELOVL6, ELOVL3, ELOVL5 | LDHA 1358/4885CDK1 2134/4885CCNB1 951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.